Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations
: Action PharmaKitDx demonstrates high analytical performance and broad clinical applicability, supporting its implementation as a scalable solution for comprehensive pharmacogenetic testing and precision prescribing.
Authors
- Antonia Obrador de Hevia
- Matías Morin (ORCID: https://orcid.org/0000-0002-7985-592X)
- Iciar Martinez-Lopez (ORCID: https://orcid.org/0000-0002-0030-718X)
- Luis Ramudo (ORCID: https://orcid.org/0000-0002-3266-0121)
- Marta Izquierdo-García
- Pau Riera (ORCID: https://orcid.org/0000-0002-3074-3927)
- Adriana Lasa (ORCID: https://orcid.org/0000-0001-9957-9646)
- Javier Porta Pelayo
- Sara Bernal (ORCID: https://orcid.org/0000-0003-4427-0574)
- Laura Torres-Juan
- Miguel Ángel Moreno-Pelayo
- Vicente Cubells-Perez
- María Dolores-Sequedo
- Greta Carmona-Antoñanzas
- Victor José Asensio
Institutions
- Universidade da Coruña (ES)
- Hospital de Sant Pau (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Health Research Institute of the Balearic Islands (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Hospital Universitario Son Espases (ES)
- Instituto de Investigación Biomédica de A Coruña (ES)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2026-04-01
- DOI
- https://doi.org/10.3390/ph19040568
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agència Valenciana de la Innovació